Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

firstwordpharma.com
firstwordpharma.com > story > 7973027

Friday Five??? Novartis' stumbles spark boardroom backlash, Nodthera name drops, FDA throws wrench into Biohaven deal???and more

2+ day, 12+ hour ago   (19+ words) Friday Five – Novartis' stumbles spark boardroom backlash, Nodthera name drops, FDA throws wrench into Biohaven deal…and more firstwordpharma.com...

FirstWord PHARMA
firstwordpharma.com > story > 7968650

Encoded pulls in $275M for pivotal study of Dravet gene therapy

3+ day, 14+ hour ago   (13+ words) FirstWord PHARMA...

FirstWord Pharma
firstwordpharma.com > story > 7965266

Physician Views Preview: How are prescribing patterns changing in COPD?

4+ day, 7+ hour ago   (12+ words) FirstWord Pharma...

FirstWord PHARMA
firstwordpharma.com > story > 7961783

Amgen claims win for Imdelltra in maintenance lung cancer setting

4+ day, 18+ hour ago   (12+ words) FirstWord PHARMA...

FirstWord Pharma
firstwordpharma.com > story > 7960381

Next-gen CAR-T from BMS passes pivotal test in quadruple-class exposed myeloma

5+ day, 43+ min ago   (13+ words) FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7960382

Moonwalk unveils gene silencing approach to obesity, $70M in fresh funds

5+ day, 39+ min ago   (13+ words) FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7960147

BrainChild Bio moves CAR-T into pivotal study for paediatric brain cancer

5+ day, 1+ hour ago   (13+ words) FirstWord Pharma...

firstwordpharma.com
firstwordpharma.com > story > 7958314

Vital Signs: Who's enjoying the fruits of pharma's labor?

5+ day, 19+ hour ago   (10+ words) firstwordpharma.com...

FirstWord PHARMA
firstwordpharma.com > story > 7944820

GSK pays up to $1.3B for HUTCHMED's experimental KRAS-EGFR conjugate

1+ week, 3+ day ago   (12+ words) FirstWord PHARMA...

FirstWord Pharma
firstwordpharma.com > story > 7940898

uniQure submits long-awaited filing for Huntington's gene therapy

1+ week, 3+ day ago   (10+ words) FirstWord Pharma...